| AQGNX | FWGIX | AQGNX / FWGIX | |
| Total Expense Ratio | 1.07 | 0.41 | 261% |
| Annual Report Gross Expense Ratio | 1.09 | 0.41 | 266% |
| Fund Existence | 16 years | 9 years | - |
| Gain YTD | 17.198 | 14.741 | 117% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 1000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 545M | 142B | 0% |
| Annual Yield % from dividends | 1.46 | 1.64 | 89% |
| Returns for 1 year | 15.52 | 12.68 | 122% |
| Returns for 3 years | 56.19 | 47.61 | 118% |
| Returns for 5 years | 40.13 | 32.97 | 122% |
| Returns for 10 years | 79.15 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| GVLU | 24.99 | 0.02 | +0.09% |
| Gotham 1000 Value ETF | |||
| IBIH | 26.02 | 0.01 | +0.06% |
| iShares iBonds Oct 2031 Term Tips ETF | |||
| VTIP | 49.44 | 0.03 | +0.05% |
| Vanguard Short-Term Infl-Prot Secs ETF | |||
| SPBX | 27.58 | N/A | +0.01% |
| AllianzIM 6 Month Buffer10 Allocation ETF | |||
| IHE | 86.15 | -0.06 | -0.07% |
| iShares US Pharmaceuticals ETF | |||